Foscarnet Kabi

Foscarnet Sodium Hexahydrate is an antiviral medication used for intravenous administration. It is primarily indicated for the treatment of certain viral infections, including those caused by herpesviruses. This medication is manufactured by Fresenius Kabi Italia S.R.L. and is available in the EU market.

Foscarnet Sodium Hexahydrate is used to treat viral infections, particularly those caused by herpesviruses. It is often prescribed for conditions where other antiviral treatments may not be effective. The medication works by inhibiting the replication of the virus, helping to control the infection. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of Foscarnet Sodium Hexahydrate may include nausea, vomiting, and changes in kidney function. Some patients may also experience electrolyte imbalances or infusion-related reactions. It is important to monitor for any adverse effects and report them to a healthcare professional.

Foscarnet Sodium Hexahydrate should be handled with care and administered under the supervision of a healthcare professional. Patients with pre-existing kidney conditions should be monitored closely. Proper hydration and electrolyte balance are crucial during treatment. Always follow the guidance of a healthcare provider when using this medication.

Foscarnet Sodium Hexahydrate may interact with other medications, particularly those that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the efficacy and safety of this medication.